Comparison of benign keratoses using p53, bcl-1, and bcl-2

Journal of Cutaneous Pathology

Volumn 32, Issue 5, 2005, Pages 356-359

  Ko, Christine J ^a   Shintaku, Peter ^a   Binder, Scott W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN; PROTEIN BCL 1; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; DARIER DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOSIS; SEBORRHEIC KERATOSIS; STAINING; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

BIOLOGICAL MARKERS; CELL CYCLE; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATOSIS; KERATOSIS FOLLICULARIS; KERATOSIS, SEBORRHEIC; PROTO-ONCOGENE PROTEINS C-BCL-2; STAINING AND LABELING; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17444406639     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00328.x     Document Type: Article

References (16)

1. Yamamoto H, Ochiya T, Takeshita F, et al. Enhanced skin carcinogenesis in cyclin D1-conditonal transgenic mice: cyclin D1 alters keratinocyle response to calcium-induced terminal differentiation. Cancer Res 2002; 62: 1641.
2. Mate JL, Ariza A, Roca X, et al. Expression patterns of cyclins D1 and E in condyloma acuminatium in comparison with psoriatic proliferative lesions. J Pathol 1998; 184: 83.
3. Sellheyer K, Krahl D, Ratech H. Distribution of bcl-2 and bax in embryonic and fetal human skin. Am J Dermatopathol 2001; 23: 1.
4. Nakagawa K, Yamamura K, Maeda S, et al. Bcl-2 expression in epidermal keratinocytic diseases. Cancer 1994; 74: 1720.
5. Mevorah B, Mishima Y. Cellular response of seborrheic keratosis following croton oil irritation and surgical trauma. Dermatologica 1965; 131: 452.
6. Kirkham N. Tumors and cysts of the epidermis. In Elder D, ed. Lever's Histopathology of the Skin, 8th ed. Philadelphia: Lippincott-Raven, 1997; 685.
7. Maize JC, Burgdorf WHC, Hurt M, et al. Tumors of the epidermis. In Maize JC, et al., eds. Cutaneous Pathology. Philadelphia: Churchill Livingstone, 1998; 439.
8. Boyd AS. Tumors of the epidermis. In Barnhill RL, ed. Textbook of Dermatopathology. New York: McGraw-Hill, 1998; 493.
9. Berman A, Winkelmann RK. Seborrheic keratoses: appearance in course of exfoliative erythroderma and regression associated with histologic mononuclear cell inflammation. Arch Dermatol 1982; 118: 615.
10. Berman A, Winkelmann RK. Inflammatory seborrheic keratoses with mononuclear cell infiltration. J Cutan Pathol 1978; 5: 353.
11. Pesce C, Scalora S. Apoptosis in the areas of squamous differentiation of irritated seborrheic keratosis. J Cutan Pathol 2000; 27: 121.
12. Nakamura S, Nishioka K. Enhanced expression of p16 in seborrhoeic keratoses; a lesion of accumulated senescent epidermal cells in G1 arrest. Br J Dermatol 2003; 149: 560.
13. Chen QM, Liu J, Merrett JB. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J 2000; 347: 543.
14. Erkek E, Bozdogan O, Atasoy P, et al. Bcl-2-related apoptosis markers in cutaneous human papillomavirus-associated lesions. Am J Dermatopathol 2004; 26: 113.
15. Plettenberg A, Ballaun C, Pammer J, et al. Human melanocytes and melanoma cells constitutively express the bcl-2 protooncogene in situ and in cell culture. Am J Pathol 1995; 146: 651.
16. Isaacson PG, Norton AJ. Cutaneous lymphoma. Isaacson PG, Norton AJ, eds. In Extranodal Lymphomas. Edinburgh: Churchill Livingstone 1994, 131.